Aspen Pharmacare Targets Canadian Market with Ozempic Generic by Q3 2026

Aspen Pharmacare, a South African drugmaker, plans to enter the Canadian market with a generic version of Novo Nordisk’s blockbuster diabetes and weight-loss drug Ozempic by the third quarter of 2026. The move aims to capitalize on the soaring demand for GLP-1 receptor agonists amid a global shortage of the branded medication. The company is […] The post Aspen Pharmacare Targets Canadian Market with Ozempic Generic by Q3 2026 appeared first on the deep dive.